• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

February 7, 2018

Link Between Heart, Eye Damage in Type 1 Diabetes Discovered

Author(s):

Gina Kokosky, Editorial Intern

The mechanisms of blood vessel damage from diabetes may affect damage to the heart and eyes.

Patients with type 1 diabetes (T1D) are at risk for blood vessel damage to the kidneys, eyes, heart, and other organs due to uncontrolled levels of glucose in their blood.

The damage was originally believed to be inflicted by different mechanisms of each individual organ; however, similar mechanisms may be causing damage to blood vessels of the heart and eye, according to a study published by Diabetes Care.

These findings could help researchers develop a new way to prevent and treat diabetes-related complications in the future.

Cardiovascular disease is the leading cause of death among patients with T1D, while patients with kidney disease have a much higher chance of developing heart disease, according to the authors.

Proliferative diabetic retinopathy has also been linked to cardiovascular disease among patients with T1D.

Identifying the relationship between eye complications and cardiovascular disease was challenging, as most patients with chronic kidney disease also have eye damage, according to the authors.

The study examined hundreds of patients who have lived with diabetes for more than 50 years. Out of these patients, the authors only found 30 who had chronic kidney disease but did not experience eye damage.

The authors were surprised to find that patients with kidney disease did not particularly have higher rates of cardiovascular disease.

“This is an unexpected finding,” said corresponding author George King, MD. “It suggests that biological factors that either protect against or boost damage to blood vessels are shared between the eye and cardiovascular system, but they may be different from those affecting the kidney.”

The authors then confirmed their findings by investigating data from The Finnish Diabetic Nephropathy study.

This study, which began in 1997, has collected genetic and physical information from more than 5500 patients who have had diabetes for at least 25 years. The results showed that the onset of kidney failure will usually occur in patients with T1D who are predisposed to it.

The study also confirmed that high glucose levels do not damage all blood vessels in the same way, according to the authors.

The authors noted that there was no link between cardiovascular damage and nerve damage, while eye damage appeared to be correlated with cardiovascular damage. This further suggests that the injuries to the blood vessels of the eye and heart may be caused by the same mechanisms, according to the study.

Continuing forward, the authors plan to examine heart scans to find a connection between heart damage and damage to other organs.

“We hope that will give us the next set of clues to understand and guard against these complications,” Dr King said.

Related Videos
5 experts in this video
5 experts in this video
1 expert is featured in this series.
Related Content
Advertisement
Camber Pharmaceuticals Announces Addition of Temozolomide Capsules, USP
May 15th 2025

Camber Pharmaceuticals Announces Addition of Temozolomide Capsules, USP

pharmacy focus oncology edition
May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
Olaparib box | Image Credit: © luchschenF - stock.adobe.com
May 15th 2025

Gap-Scheduled Olaparib Plus Neoadjuvant Chemotherapy Improved Survival in Patients With gBRCAm TBNC

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Used empty packaging from pills close up. Many different pill blister silver pharmaceutical packaging foils. Drug shortage concept - Image credit: Sopear | stock.adobe.com
May 15th 2025

Medication Meltdown: Unpacking Drug Shortages

Kortney J. Knudsen, BS
Intestinal carcinoma, colorectal cancer, bowel neoplasia, 3D illustration
May 15th 2025

High LDL Cholesterol Associated With Earlier Progression in Synchronous Metastatic Colorectal Cancer

Luke Halpern, Assistant Editor
Related Content
Advertisement
Camber Pharmaceuticals Announces Addition of Temozolomide Capsules, USP
May 15th 2025

Camber Pharmaceuticals Announces Addition of Temozolomide Capsules, USP

pharmacy focus oncology edition
May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
Olaparib box | Image Credit: © luchschenF - stock.adobe.com
May 15th 2025

Gap-Scheduled Olaparib Plus Neoadjuvant Chemotherapy Improved Survival in Patients With gBRCAm TBNC

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Used empty packaging from pills close up. Many different pill blister silver pharmaceutical packaging foils. Drug shortage concept - Image credit: Sopear | stock.adobe.com
May 15th 2025

Medication Meltdown: Unpacking Drug Shortages

Kortney J. Knudsen, BS
Intestinal carcinoma, colorectal cancer, bowel neoplasia, 3D illustration
May 15th 2025

High LDL Cholesterol Associated With Earlier Progression in Synchronous Metastatic Colorectal Cancer

Luke Halpern, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.